DANIEL MICHAEL GREEN
Pharmacy in Prospectville, PA
License number
Pennsylvania PI113883
Category
Pharmacy
Type
Pharmacy Intern
Address
Address
Prospectville, PA 19002
Personal information
See more information about DANIEL MICHAEL GREEN at radaris.comName
Address
Phone
4 Loggers Mill Rd, Horsham, PA 19044
4 Delancey Pl, Downingtown, PA 19335
4980 State Rd #310, Drexel Hill, PA 19026
49 Betsy Ln, Ambler, PA 19002
45 Wharton Dr, Glen Mills, PA 19342
Professional information
Aryl Sulfonic Acids And Derivatives As Fsh Antagonists
US Patent:
6355633, Mar 12, 2002
Filed:
Mar 24, 2000
Appl. No.:
09/535492
Inventors:
Jay E. Wrobel - Lawrenceville NJ
John F. Rogers - Bryn Mawr PA
Daniel M. Green - Ambler PA
Wenling Kao - Paoli PA
James W. Jetter - Norristown PA
John F. Rogers - Bryn Mawr PA
Daniel M. Green - Ambler PA
Wenling Kao - Paoli PA
James W. Jetter - Norristown PA
Assignee:
American Home Products Corporation - Madison NJ
International Classification:
A61K 31167
US Classification:
51421201, 5142382, 51425211, 5142275, 514445, 514709, 514408, 514316
Abstract:
This invention provides compounds of formula I having the structure wherein R , Ar, Arâ², and Q are as defined in the specification, or a pharmaceutically acceptable salt thereof, which are useful as contraceptive agents.
Sulfonic Acid Or Sulfonylamino N-(Heteroaralkyl)-Azaheterocyclylamide Compounds
US Patent:
6602864, Aug 5, 2003
Filed:
Jun 3, 1998
Appl. No.:
09/090492
Inventors:
Yong Mi Choi-Sledeski - Collegeville PA
Henry W. Pauls - Collegeville PA
Jeffrey N. Barton - Philadelphia PA
William R. Ewing - Downingtown PA
Daniel M. Green - Ambler PA
Michael R. Becker - Norristown PA
Yong Gong - Norristown PA
Henry W. Pauls - Collegeville PA
Jeffrey N. Barton - Philadelphia PA
William R. Ewing - Downingtown PA
Daniel M. Green - Ambler PA
Michael R. Becker - Norristown PA
Yong Gong - Norristown PA
Assignee:
Aventis Pharma Deutschland GmbH - Frankfurt
International Classification:
A61K 3155
US Classification:
51421002, 51421004, 51421009, 51421016, 51421021, 51421207, 51421208, 51421301, 51421707, 514307, 514309, 514310, 540203, 540354, 540356, 540363, 540364, 540523, 540524, 540593, 540594, 540595, 540597, 546139, 546141, 546142, 546143, 546145, 546146
Abstract:
The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, which are for treating a patient suffering from, or subject to, physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
Aryl Sulfonic Acids And Derivatives As Fsh Antagonists
US Patent:
2002011, Aug 15, 2002
Filed:
Jan 10, 2002
Appl. No.:
10/043442
Inventors:
Jay Wrobel - Lawrenceville NJ, US
John Rogers - Bryn Mawr PA, US
Daniel Green - Ambler PA, US
Wenling Kao - Paoli PA, US
James Jetter - Norristown PA, US
John Rogers - Bryn Mawr PA, US
Daniel Green - Ambler PA, US
Wenling Kao - Paoli PA, US
James Jetter - Norristown PA, US
Assignee:
American Home Products Corporation - Madison NJ
International Classification:
A61K031/444, A61K031/4439, A61K031/4025, A61K031/185, A61K031/18, C 07D 4 3/02, C 07D 4 1/02
US Classification:
514/332000, 514/343000, 514/422000, 514/553000, 514/603000, 546/255000, 546/276400, 548/518000, 562/047000
Abstract:
This invention provides compounds of formula I having the structure
wherein Q is hydrogen or —SOR; X is a bond, O, S(O), —CH CH—, —CHCH—, —C≡C—, or —CHS(O)CH—; Ris OH, NH, Cto Calkoxy, Cto Cperfluoroalkoxy;
Rand Rare each, independently, hydrogen, OR, —S(O)R, —NHR, —N(R), or —CHSOCH; Rand Rare each, independently, hydrogen, —NO, —NH, —SOR, or —CHR; Ris hydrogen, Cto Calkyl, Cto Calkenyl, —CHCHZ, —CHCOR, —CHCH CHCOR
Yand Yare each, independently, N, or CH; Yand Yare each independently, O, S, or NR; Ris —OR, —NHR, —N(R), or —NHCHCHOR; Z is —OR, —OCHCHOR, —N(R), or
Ris hydrogen, or Cto Calkyl; Ris Cto Calkyl, Cto Calkenyl, OH, NHR, N(R), CHCOR, —CHCH CHCOR, or
Ris Cto Calkyl, Cto Calkenyl, phenyl, —CHCHOCH, or
Ris —OR, NHR, —N(R), or —NHCHCHOR; Ris hydrogen, or Cto Calkyl; Ris hydrogen, or Cto Calkyl; W is a bond, CH, CHCH, O, S(O), NCHO, NCOCH, or NR; m is 0-2; n is 0-2; q is 0-2, with the proviso that Rand Rare not both hydrogen; or pharmaceutically acceptable salt thereof, which are useful as contraceptive agents.
Benzooxazole And Benzothiazole Antagonists Of Gonadotropin Releasing Hormone Receptor
US Patent:
7531542, May 12, 2009
Filed:
May 9, 2006
Appl. No.:
11/431266
Inventors:
Daniel M. Green - Ambler PA, US
Diane B. Hauze - Radnor PA, US
Charles W. Mann - Philadelphia PA, US
Jeffrey C. Pelletier - Lafayette Hill PA, US
Matthew D. Vera - Royersford PA, US
Diane B. Hauze - Radnor PA, US
Charles W. Mann - Philadelphia PA, US
Jeffrey C. Pelletier - Lafayette Hill PA, US
Matthew D. Vera - Royersford PA, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/497, C07D 413/00, C07D 417/00, C07D 419/00
US Classification:
51425402, 544368
Abstract:
The present invention relates to Gonadotropin Releasing Hormone (GnRH, also known as Luteinizing Hormone Releasing Hormone) receptor antagonists.
Novel Bicyclic And Tricyclic Pyrrolidine Derivatives As Gnrh Antagonists
US Patent:
2002006, May 30, 2002
Filed:
May 18, 2001
Appl. No.:
09/860810
Inventors:
Ge Peng - Mountain View CA, US
Mark Gallop - Los Altos CA, US
Stephen Yanofsky - Palo Alto CA, US
Jeffrey Pelletier - Lafayette Hill PA, US
Daniel Green - Ambler PA, US
Mark Gallop - Los Altos CA, US
Stephen Yanofsky - Palo Alto CA, US
Jeffrey Pelletier - Lafayette Hill PA, US
Daniel Green - Ambler PA, US
International Classification:
A61K031/4188, C07D487/14
US Classification:
514/387000, 548/302400
Abstract:
Bicyclic and tricyclic pyrrolidine derivatives are disclosed that are useful as antagonists of the GnRH receptor. Methods for using the novel compounds to treat GnRH-related disorders are also provided, as are pharmaceutical compositions and novel synthetic methods.
Sulfonic Acid Sulfonylamino N-(Heteroaralkyl)-Azaheterocyclylamide Compounds
US Patent:
6281227, Aug 28, 2001
Filed:
Dec 2, 1999
Appl. No.:
9/453307
Inventors:
Yong Mi Choi-Sledeski - Collegeville PA
Heinz W. Pauls - Collegeville PA
Jeffrey N. Barton - Philadelphia PA
William R. Ewing - Downingtown PA
Daniel M. Green - Ambler PA
Michael R. Becker - Norristown PA
Yong Gong - Norristown PA
Julian Levell - Royersford PA
Heinz W. Pauls - Collegeville PA
Jeffrey N. Barton - Philadelphia PA
William R. Ewing - Downingtown PA
Daniel M. Green - Ambler PA
Michael R. Becker - Norristown PA
Yong Gong - Norristown PA
Julian Levell - Royersford PA
Assignee:
Aventis Pharma Deutschland GmbH - Frankfurt
International Classification:
A61K 3147, A61K 3155, C07D20508, C07D23900, C07D21700
US Classification:
514307
Abstract:
The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, for treating a patient suffering from, or subject to, a physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
Naphthylpyrimidine, Naphthylpyrazine And Naphthylpyridazine Analogs And Their Use As Agonists Of The Wnt-Beta-Catenin Cellular Messaging System
US Patent:
2009005, Feb 26, 2009
Filed:
Aug 19, 2008
Appl. No.:
12/194235
Inventors:
Jeffrey Claude Pelletier - Lafayette Hill PA, US
Luciana de Araujo Felix - Broomall PA, US
Daniel Michael Green - Ambler PA, US
Diane Barbara Hauze - Wayne PA, US
Charles William Mann - Plymouth Meeting PA, US
John Francis Mehlmann - King of Prussia PA, US
Matthew Douglas Vera - Collegeville PA, US
Albert John Molinari - Pottstown PA, US
Luciana de Araujo Felix - Broomall PA, US
Daniel Michael Green - Ambler PA, US
Diane Barbara Hauze - Wayne PA, US
Charles William Mann - Plymouth Meeting PA, US
John Francis Mehlmann - King of Prussia PA, US
Matthew Douglas Vera - Collegeville PA, US
Albert John Molinari - Pottstown PA, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/397, C07D 239/24, A61K 31/505, C07D 243/08, C07D 413/14, A61K 31/496, A61P 19/08, A61P 25/28, A61P 35/00, A61K 31/5377, A61K 31/551, C07D 403/02, A61K 31/55
US Classification:
5142102, 544330, 514275, 540575, 514218, 540601, 51421706, 544121, 5142358, 51425214
Abstract:
The present invention relates to naphthylpyrimidine analogs, methods of making naphthylpyrimidine analogs, compositions comprising a naphthylpyrimidine analog, and methods for treating canonical Wnt-β-catenin cellular messaging system-related disorders comprising administering to a subject in need thereof an effective amount of a naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analog.
Gonadotropin Releasing Hormone Receptor Antagonists
US Patent:
2006011, May 25, 2006
Filed:
Nov 23, 2005
Appl. No.:
11/286081
Inventors:
Lloyd Garrick - Arvada CO, US
Daniel Green - Ambler PA, US
James Jetter - Norristown PA, US
Wenling Kao - Fremont CA, US
Kenneth Kees - Glenmoore PA, US
Jeffrey Pelletier - Lafayette Hill PA, US
John Rogers - Bryn Mawr PA, US
Daniel Green - Ambler PA, US
James Jetter - Norristown PA, US
Wenling Kao - Fremont CA, US
Kenneth Kees - Glenmoore PA, US
Jeffrey Pelletier - Lafayette Hill PA, US
John Rogers - Bryn Mawr PA, US
Assignee:
WYETH - Madison NJ
International Classification:
A61K 31/506, A61K 31/496, A61K 31/501, A61K 31/498, C07D 403/14, C07D 413/14, C07D 417/14
US Classification:
514248000, 514254090, 514249000, 514252190, 514252110, 514253060, 514254050, 514254060, 514253050, 544236000, 544295000, 544333000, 544357000, 544360000, 544363000, 544368000, 544373000, 514254020
Abstract:
The present invention relates to Gonadotropin Releasing Hormone (“GnRH”) (also known as Luteinizing Hormone Releasing Hormone) receptor antagonists.
Gonadotropin Releasing Hormone Receptor Antagonists
US Patent:
7696210, Apr 13, 2010
Filed:
Jun 16, 2005
Appl. No.:
11/154795
Inventors:
Lloyd Michael Garrick - Arvada CO, US
Daniel Michael Green - Ambler PA, US
Diane Barbara Hauze - St. Davids PA, US
Kenneth Lewis Kees - Glenmoore PA, US
Charles William Mann - Philadelphia PA, US
John Francis Mehlmann - King of Prussia PA, US
Jeffrey Claude Pelletier - Lafayette Hill PA, US
Jay Edward Wrobel - Lawrenceville NJ, US
Daniel Michael Green - Ambler PA, US
Diane Barbara Hauze - St. Davids PA, US
Kenneth Lewis Kees - Glenmoore PA, US
Charles William Mann - Philadelphia PA, US
John Francis Mehlmann - King of Prussia PA, US
Jeffrey Claude Pelletier - Lafayette Hill PA, US
Jay Edward Wrobel - Lawrenceville NJ, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/497, C07D 403/00
US Classification:
51425406, 544370
Abstract:
Compounds of Formula I, useful as Gonadotropin Releasing Hormone (“GnRH”) (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists, are disclosed.